CTRI/2024/07/070282
Not yet recruiting
Phase 2
Evaluation of efficacy of add on oral levofloxacin in children with tubercular meningitis aged 6 months-18 years: A randomized controlled trial - NI
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: A170- Tuberculous meningitis
- Sponsor
- All India Institute of Medical Sciences, Rishikesh
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosed cases of tubercular meningitis presenting to Department of Pediatrics, All India Institute Medical Sciences, Rishikesh with a diagnosis of TB meningitis as per Marais’ criteria and parents willing to comply with the study protocol and follow up
Exclusion Criteria
- •Pre\-existing major chronic systemic illness including cardiovascular (arrhythmia, prolonged QTc interval or history of any arrhythmia), respiratory (chronic lung disease), gastrointestinal system (chronic liver disease) or chronic renal disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Evaluation of the effect of oral levofloxacin on chronic endometritis in patientsIRCT20220413054524N1Shahre-kord University of Medical Sciences60
Recruiting
Phase 1
Efficacy of levofloxacin and colistin inhalation form in treatment of pneumoniaVentilator associated pneumonia (VAP) caused by multidrug resistant pathogens.Ventilator associated pneumoniaJ95.851IRCT20100107003014N26Mazandaran University of Medical Sciences70
Completed
Phase 2
Comparing the effect of levofloxacin with azithromycin in improving pulmonary function of patients with bronchiectasisIRCT20100102002954N28Shahroud University of Medical Sciences72
Completed
Not Applicable
Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in KoreaHelicobacter pylori infectionJPRN-UMIN000015375Severance Hospital, Yonsei University200
Completed
Not Applicable
Efficacy and Safety of treatment with Levofloxacin for Community-acquired PneumoniaCommunity-acquired pneumonia in adultsJPRN-UMIN000008677Second Division, Department of Internal Medicine, Hamamatsu university school of medicine300